Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. (Q39062014)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 December 2016

Language	Label	Description	Also known as
English	Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.	scientific article published on 27 December 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Dominic Boardman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Christina Philippeos

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Gilbert Fruhwirth

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Mohammad A A Ibrahim

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

author name string

R F Hannen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

D Cooper

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

F M Marelli-Berg

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

R I Lechler

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

L A Smyth

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

G Lombardi

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

language of work or name

0 references

publication date

1 February 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

American Journal of Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

931-943

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

IL-6 promotes cardiac graft rejection mediated by CD4+ cells

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Long-term prevention of chronic allograft rejection by regulatory T-cell immunotherapy involves host Foxp3-expressing T cells.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Relevance of regulatory T cell promotion of donor-specific tolerance in solid organ transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Indefinite mouse heart allograft survival in recipient treated with CD4(+)CD25(+) regulatory T cells with indirect allospecificity and short term immunosuppression.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Pathways of allorecognition: implications for transplantation tolerance

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Promoting transplantation tolerance; adoptive regulatory T cell therapy

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

The search for CNI-free immunosuppression: no free lunch.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Tofacitinib in kidney transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Regulatory T cells: how do they suppress immune responses?

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

FOXP3: genetic and epigenetic implications for autoimmunity

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Human FoxP3+ regulatory T cells in systemic autoimmune diseases

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

The number of regulatory T cells in transbronchial lung allograft biopsies is related to FoxP3 mRNA levels in bronchoalveolar lavage fluid and to the degree of acute cellular rejection

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Type 1 diabetes immunotherapy using polyclonal regulatory T cells

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Novel GMP-compatible protocol employing an allogeneic B cell bank for clonal expansion of allospecific natural regulatory T cells.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Antigen-specificity using chimeric antigen receptors: the future of regulatory T-cell therapy?

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

CARs on track in the clinic

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Use of gene-modified regulatory T-cells to control autoimmune and alloimmune pathology: is now the right time?

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

The isolation and characterisation of human monoclonal HLA-A2 antibodies from an immune V gene phage display library

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Fiji: an open-source platform for biological-image analysis

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4(+)CD25(+)FOXP3(+) T regulatory cell subpopulations

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Human T regulatory cells can use the perforin pathway to cause autologous target cell death

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

CD31 exhibits multiple roles in regulating T lymphocyte trafficking in vivo

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Marker succession during the development of keratinocytes from cultured human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

HLA-A, -B, -DR allele group frequencies in 7007 kidney transplant list patients in 27 UK centres

1 reference

https://api.crossref.org/works/10.1111%2FAJT.14185

21 January 2018

Identifiers

10.1111/AJT.14185

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28027623%20AND%20SRC:MED&resulttype=core&format=json

3 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39062014&oldid=2196910761"